These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 22901702
1. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. Park SG, Lee JH, Lee WA, Han KM. Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702 [Abstract] [Full Text] [Related]
2. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M. Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231 [Abstract] [Full Text] [Related]
3. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Shim HK, Lee WW, Park SY, Kim H, So Y, Kim SE. Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531 [Abstract] [Full Text] [Related]
4. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J. Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473 [Abstract] [Full Text] [Related]
5. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. Shim HK, Lee WW, Park SY, Kim H, Kim SE. Oncol Res; 2009 Oct; 17(7):331-7. PubMed ID: 19408578 [Abstract] [Full Text] [Related]
6. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis. Zhao Z, Yoshida Y, Kurokawa T, Kiyono Y, Mori T, Okazawa H. J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314 [Abstract] [Full Text] [Related]
7. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, Lee MC, Kim SE. Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874 [Abstract] [Full Text] [Related]
8. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, Doi R, Hosotani R, Imamura M, Konishi J. J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481 [Abstract] [Full Text] [Related]
9. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Lyshchik A, Higashi T, Hara T, Nakamoto Y, Fujimoto K, Doi R, Imamura M, Saga T, Togashi K. Cancer Invest; 2007 Feb; 25(3):154-62. PubMed ID: 17530485 [Abstract] [Full Text] [Related]
10. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642 [Abstract] [Full Text] [Related]
11. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II. Ong LC, Jin Y, Song IC, Yu S, Zhang K, Chow PK. Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289 [Abstract] [Full Text] [Related]
12. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N. J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491 [Abstract] [Full Text] [Related]
13. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results. Christlieb SB, Strandholdt CN, Olsen BB, Mylam KJ, Larsen TS, Nielsen AL, Rohde M, Gerke O, Olsen KE, Møller MB, Kristensen BW, Abildgaard N, Alavi A, Høilund-Carlsen PF. Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266 [Abstract] [Full Text] [Related]
14. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ. Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711 [Abstract] [Full Text] [Related]
15. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K. Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368 [Abstract] [Full Text] [Related]
16. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. Watanabe Y, Suefuji H, Hirose Y, Kaida H, Suzuki G, Uozumi J, Ogo E, Miura M, Takasu K, Miyazaki K, Nakahara K, Ishibashi M, Okamura T, Ohshima K, Hayabuchi N. Int J Hematol; 2013 Jan; 97(1):43-9. PubMed ID: 23212465 [Abstract] [Full Text] [Related]
17. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Nguyen XC, Lee WW, Chung JH, Park SY, Sung SW, Kim YK, So Y, Lee DS, Chung JK, Lee MC, Kim SE. Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556 [Abstract] [Full Text] [Related]
18. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung. Song YS, Lee WW, Chung JH, Park SY, Kim YK, Kim SE. Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496 [Abstract] [Full Text] [Related]
19. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Aloj L, Caracó C, Jagoda E, Eckelman WC, Neumann RD. Cancer Res; 1999 Sep 15; 59(18):4709-14. PubMed ID: 10493529 [Abstract] [Full Text] [Related]
20. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Mamede M, Higashi T, Kitaichi M, Ishizu K, Ishimori T, Nakamoto Y, Yanagihara K, Li M, Tanaka F, Wada H, Manabe T, Saga T. Neoplasia; 2005 Apr 15; 7(4):369-79. PubMed ID: 15967114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]